Deutsche Bank
CLYM

Deutsche Bank’s Climb Bio CLYM Stock Holding History

Deutsche Bank’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$452K Buy
34,673
+34,672
+3,467,200% +$358K ﹤0.01% 2827
2026
Q1 		$7 Hold
1
– – ﹤0.01% 3614
2025
Q4 		$4 Hold
1
– – ﹤0.01% 3617
2025
Q3 		$2 Sell
1
-12,381
-100% -$23K ﹤0.01% 3600
2025
Q2 		$15.4K Buy
+12,382
New +$15.4K ﹤0.01% 3495
2022
Q2 		– Sell
-3,841
Closed -$32K – 4357
2022
Q1 		$32K Sell
3,841
-452
-11% -$4.22K ﹤0.01% 3966
2021
Q4 		$45K Buy
4,293
+230
+6% +$3.43K ﹤0.01% 3983
2021
Q3 		$73K Buy
+4,063
New +$83.9K ﹤0.01% 4019

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank's CLYM Position: Q2 2026 in Review

Deutsche Bank increased its Climb Bio (CLYM) stake by 3,467,200% in Q2 2026, buying an estimated $358K and bringing the position to 34,673 shares worth $452K. The position accounts for ﹤0.01% of the portfolio, ranked #2827.

Deutsche Bank first reported a position in CLYM in Q3 2021 and has held it in 8 quarters since. 108 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Deutsche Bank held 34,673 shares of Climb Bio worth $452K as of Q2 2026.
  • Deutsche Bank bought 34,672 Climb Bio shares in Q2 2026, an estimated $358K.
  • Climb Bio made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2827 holding.
  • Deutsche Bank first reported a position in Climb Bio in Q3 2021 and has held it in 8 quarters since.
  • 108 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.